Skip to main content


The Paediatric Society of New Zealand provides information available to the public on all matters that concern the health and welfare of children and advancing public education and awareness of the science and practice of paediatrics, child health and welfare of children.

Paediatric Vaccines Research Review - Issue 44

Created: 18/12/2020

In this issue, a US phase 1 trial supports the selection of the COVID-19 vaccine candidate BNT162b2 for advancement to phase 2–3 safety and efficacy evaluation, an interesting article discusses an ethical framework for global COVID-19 vaccine allocation, and a brief communication hot off the press indicates that the Pfizer mRNA vaccine has the potential to provide durable humoral immunity.


Back to resource list